Cargando…
HIV experts on the decision to use early ART for prevention in France: are we there yet?
Autores principales: | Lebouché, Bertrand, Engler, Kim, Lévy, Joseph Josy, Gimore, Spire, Bruno, Rozenbaum, Willy, Routy, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360363/ http://dx.doi.org/10.1186/1742-4690-9-S1-P95 |
Ejemplares similares
-
Evaluation of a project to engage patients in the development of a patient‐reported measure for HIV care (the I‐Score Study)
por: Lessard, David, et al.
Publicado: (2018) -
P15-02. Participation in immune-based therapy trial excludes participation in future trials: solving this problem
por: Routy, J, et al.
Publicado: (2009) -
Abandoned embryos in Brazil: advances in the decisions. Are we there
yet?
por: de Souza, Maria do Carmo Borges, et al.
Publicado: (2018) -
State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
por: Mosarla, Ramya C., et al.
Publicado: (2022) -
Genomics-based breeding in forest trees: are we there yet?
por: Neale, David
Publicado: (2011)